5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.95▲ | 3.01▼ | 3.07▼ | 3.16▼ | 2.67▲ |
MA10 | 2.98▲ | 3.05▼ | 3.14▼ | 2.85▲ | 2.53▲ |
MA20 | 3.04▼ | 3.12▼ | 3.17▼ | 2.66▲ | 2.83▲ |
MA50 | 3.11▼ | 3.14▼ | 2.91▲ | 2.56▲ | 3.85▼ |
MA100 | 3.14▼ | 2.86▲ | 2.70▲ | 2.89▲ | 4.26▼ |
MA200 | 3.11▼ | 2.68▲ | 2.49▲ | 3.70▼ | 5.17▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.027▼ | -0.044▼ | 0.075▲ | 0.082▲ |
RSI | 41.805▼ | 41.025▼ | 44.639▼ | 58.357▲ | 47.994▼ |
STOCH | 39.394 | 20.161 | 17.174▼ | 89.028▲ | 52.416 |
WILL %R | -62.500 | -72.308 | -78.049▼ | -33.560 | -29.305 |
CCI | -19.178 | -111.584▼ | -177.515▼ | 63.897 | 78.619 |
Tuesday, May 20, 2025 05:44 AM
Achieve Life Sciences will present Phase 3 study data on cytisinicline's efficacy in nicotine craving reduction at the ATS Conference. Achieve Life Sciences, Inc. has announced that additional ...
|
Wednesday, May 14, 2025 05:30 AM
Q1 2025 Earnings Call Transcript May 13, 2025 Achieve Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.36981, expectations were $-0.37. Operator: Greetings. Welcome to Achieve Life ...
|
Wednesday, May 14, 2025 02:21 AM
ACHV READ THE FULL ACHV RESEARCH REPORT Achieve Life Sciences, Inc. (NASDAQ:ACHV) reported its first quarter 2025 results, highlighting progress on the ORCA-OL study, preparation of the New Drug ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
22/05/25 | 3.04 | 3.04 | 2.90 | 2.99 | 39,543 |
21/05/25 | 3.22 | 3.2662 | 3.031 | 3.14 | 176,503 |
20/05/25 | 3.30 | 3.32 | 2.96 | 3.26 | 561,745 |
19/05/25 | 3.13 | 3.31 | 3.03 | 3.31 | 508,518 |
16/05/25 | 2.75 | 3.10 | 2.68 | 3.08 | 564,770 |
15/05/25 | 2.51 | 2.74 | 2.475 | 2.73 | 125,675 |
14/05/25 | 2.64 | 2.655 | 2.42 | 2.48 | 141,188 |
13/05/25 | 2.56 | 2.67 | 2.4857 | 2.65 | 174,835 |
12/05/25 | 2.43 | 2.54 | 2.41 | 2.48 | 125,166 |
09/05/25 | 2.44 | 2.5291 | 2.34 | 2.35 | 128,717 |
|
|
||||
|
|
||||
|
|